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The Netherlands
Objective. The primary aim of ultrasound follow-up after aorto-iliac prosthetic reconstruction is to correct false aneurysms
before rupture occurs. We investigated whether follow-up improves the life expectancy of patients and sought to identify the
most cost-effective follow-up strategy.
Design of the Study. A Monte Carlo Markov decision model was constructed. The occurrence of false aneurysms was
modelled as a time-dependent process for each anastomotic site, based on published series. Using this model, the impact of
various follow-up strategies was investigated for three types of prostheses, aorto-distal tube, aorto-bi-iliac, and aorto-bi-
femoral prostheses. Main outcome measures were discounted quality adjusted life years (dQALYs), discounted costs, and
(discounted) cost-effectiveness (CE) ratios.
Results. Follow-up of patients with aorto-distal tube and aorto-bifemoral prostheses did not result in an improvement life
expectancy and was not cost-effective, QALYs 7.53 and 7.62 years, respectively. The results for aorto-distal tube and aorto-
bifemoral prostheses were not sensitive to any variation in the model parameters. In the base case analysis, the life expectancy
of patients with aorto-bi-iliac prostheses was 7.50 QALYs (95% confidence interval 7.46–7.54) whether or not they
underwent routine follow-up. However, patients aged 54 years or younger gained 0.11 QALYs with annual follow-up
(p , 0.05). The most cost-effective strategy was annual follow-up that starts 10 years after the initial operation, and
continues up to 30 years after surgery (4600 Euro; CE ratio 21,000 Euro per QALY). When perioperative mortality of
elective reconstruction of false aneurysms is 2% or lower (e.g. when endovascular treatment is used), a small improvement is
observed (7.56 vs. 7.50 QALYs; p , 0.05; CE ratio 35,000 Euro per QALY).
Conclusions. Annual follow-up of aorto-bi-iliac prostheses should be restricted to patients aged 54 or younger and not start
before 10 years after surgery. The same strategy can only be considered for older patients if mortality for secondary
intervention is lower than 2%. Since patients with aorto-distal tube and aorto-bi-femoral prostheses do not benefit from
follow-up for the detection of false aneurysms, this practice should be discouraged in these patient groups.
Key Words: Anastomotic aneurysm; Complication; Long term outcome; Prosthetic aortic reconstruction; Long term follow
up; Decision analysis; Review; Cost-effectiveness; QALY.
Introduction
Although a rare complication after aortic prosthetic
reconstructions, false or paraanostomotic aneurysms
may occur many years after surgery.1 Rupture of such
false aneurysms, especially of those occurring in the
abdomen, is a potentially lethal complication. If a false
aneurysm in the abdomen ruptures, the probability of
death is as high as that of a ruptured primary
abdominal aneurysm.2 In contrast, elective repair of
an un-ruptured false aneurysm can be performed at an
acceptable perioperative mortality rate.3 Regular
follow-up with ultrasound or duplex examination,
has been advocated by several vascular surgeons, with
the aim of performing redo-surgery before rupture
occurs.4 – 6 The appropriate frequency and duration of
follow-up is, however, unclear, which is reflected in
the wide variation of follow-up practices among
vascular surgeons in The Netherlands.7 This is not
surprising, since the expected benefit and costs of
follow-up have not been assessed. We performed a
decision analysis and cost-effectiveness analysis to
identify the optimal strategy of follow-up after
successful prosthetic reconstruction for aorto-iliac
obstructive disease or aneurysm.
Methods
A Monte Carlo Markov decision model was
constructed,8 using the software package DATA
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(Decision Analysis by TreeAge, Boston MA) version
3.5. The course of disease was represented for all
patients who survived the initial 30-day perioperative
period without complications, using a two-level
approach.
The first (underlying) level is that of actual true
health or disease, irrespective of whether disease
states and events are observed or not. This level was
used to model the actual presence or absence of false
aneurysms at any of the vascular prosthetic anasto-
moses, which presence may or may not be noticed
clinically.
At this representation level an aorto-distal vascular
prosthesis is assumed to be at risk for four different
events. Firstly, a false aneurysm may occur at one or
more of the anastomotic sites, and, secondly, con-
ditional on its presence a false aneurysm may rupture.
Thirdly, the vascular prosthesis may be complicated
by thrombosis, and, fourthly (and rarely), infection.
The occurrence of false aneurysms was modeled as
a time dependent process per individual anastomotic
site, with an overall incidence rate of 0.01 per year on
the basis of published series. However, empirical data
show that the cumulative incidence increases more
over time than expected on the basis of a stable
incidence rate.1 For this reason, the initial incidence
rate was assumed to increase by a fixed fraction per
unit of time. Best estimates for initial rate and
fractional increase were derived from empirical
cumulative incidences at 5, 10, 15 and 20 years. Initial
rates between 0.0011 and 0.0016 (depending on the
number of vascular anastomoses), fractionally increas-
ing with 0.2 per year, led to the best fit on the basis of a
best fit between modeled and published data (Pearson
correlation coefficient of 0.98: see Appendix A for
details).
Each false aneurysm is at risk for rupture. As no
reliable data exist on the relationship between false
aneurysm diameter and rupture risk, rupture rates
were assumed to be dependent on the presence of false
aneurysms only, and not on their diameter.
Occurrence rates of prosthetic thrombosis and
infection, which are both symptomatic events that
can be observed clinically, were based on reported
data.
The second representation level is that of clinical
observations, actions and outcomes that result from
the interaction between the first-level underlying
disease processes on the one hand, and medical care
on the other.
Health and disease at this level was condensed into
the four main health states, which were further
subdivided into sub-states.
1. No Evidence of aorto-ilio-femoral Disease (NED)
2. Secondary intervention, subdivided into elective
surgery for either aorto-iliac or femoral false
aneurysm, surgery for prosthetic infection and
emergency surgery for either occlusion, rupture of
an aorto-iliac false aneurysm, or rupture of a
femoral false aneurysm.
3. After secondary intervention, subdivided into after
elective surgery, after surgery for infection, and
after emergency surgery for either graft occlusion
or rupture of a false aneurysm, and
4. Death, either from complications of aorto-ilio-
femoral disease), from medical intervention, or
from other causes.
Model assumptions
Events over time were modelled from the time of
recovery from initial aorto-ilio-femoral surgery. Time
from then on is divided into fixed-length cycles of 3
months, and per cycle a patient is assumed to occupy
only one of the available health states.
Starting the first postoperative time cycle in the
NED-state, a patient may or may not die from non-
vascular disease related causes.
Concerning the vascular trajectory just treated, a
surviving patient may or may not experience a
symptomatic event such as prosthetic occlusion or
infection, which is treated by surgery. If an (unde-
tected) false aneurysm was present, a patient may
experience false aneurysm rupture, and may either die
from rupture before reaching hospital, or be treated
clinically. Patients can develop multiple false aneur-
ysms in subsequent periods. Apart from these symp-
tomatic (and asymptomatic) events, a patient may or
may not undergo follow-up.
In an asymptomatic patient follow-up (by duplex)
may or may not detect false aneurysm(s), a screening
test being either true- or false positive or negative. In
case of positive screening, further confirmation tests
(CT-scan in our model) may either prove or disprove
the presence of a false aneurysm, a positive confir-
mation test leading to surgical treatment.
Any secondary operative intervention may be
successful, in which case the patient is classified as
NED after re-operation and survives subject to the risk
factors associated with the surgery. On the other hand
re-operation surgery may be unsuccessful, either
because a patient dies, or because cure cannot be
achieved.
Any medical intervention may result in a patient’s
death, mortality risk being dependent upon the
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procedure performed, and on the age and sex of the
patient.
As long as patients survive, they accumulate life
months and years. The amount of time lived between
initial surgery and death from any cause, is the
context-specific life expectancy of the patient. Accu-
mulated life years may be corrected for quality of life,
by multiplying the time spent in each state with the
specific quality-adjustment factor (utility) of that state.
Thus, outcome may be expressed in quality-adjusted
life years (QALYs).
Since the utilities of the specific health states after
surgery are largely unknown, the utilities of these
states were assumed to be equal to normal health.
Therefore, because only patients undergoing surgery
had a utility ,1 during surgery (and death was
assigned a utility of zero), the outcome ‘QALYs’ can in
our analyses be considered quite similar to the
intuitively more straightforward outcome ‘life years’
or ‘life expectancy’. In addition to QALYs, main
outcome parameters were costs and cost-effectiveness
ratios (a cost-effectiveness ratio is the incremental cost
of obtaining an increase of 1 QALY from a given
intervention, when compared with an alternative).9
Intermediate outcomes were the number of false
aneurysms detected, operated, and/or ruptured. To
compare cost and effect, 50,000 patients were simu-
lated for each strategy, and 95% confidence intervals
(CI) were calculated for all outcomes.
Transition probabilities
Quantitative data were obtained by systematic review
of the literature. Averages, weighted for number, were
calculated for each model parameter (Table 1). Surgical
journals have been hand searched for relevant articles
published since 1980. Additionally, we did a compu-
terized search using the MEDLINE database of the
National Library of Medicine 1966–2001, using the key
words ‘aneurysm, false’ OR ‘aneurysms, paraanosto-
motic’ combined with ‘aorta, abdominal’. Articles
were included if patients had undergone prosthetic
reconstruction for aorto-iliac occlusive disease or an
abdominal aneurysm, and patients were followed up
regularly with non-invasive diagnostic techniques for
at least 5 years. Where available, we collected
information on the incidence at the aortic, iliac and
femoral anastomosis separately.
Little is known about the probability of rupture for
a false aneurysm. Only few studies have followed up
patients with a false aneurysm conservatively. Reasons
for doing so include severe co-morbidity, refusal of the
patient to undergo surgery, or a low anticipated
rupture risk in case of small aneurysm diameter. The
overall probability of rupture in these studies was
1.5% per year. The probability of rupture for primary
aneurysms is dependent on the diameter, but is on
average estimated at 3% per year (range 1–40%).10,11
For aneurysms ,5.5 cm, the yearly rate of rupture is
estimated at 1% per year,12,13 whereas patients with
large aneurysms (5.5–7 cm) incur a risk of rupture of
approximately 10% per year.14 Rupture of false
aneurysms is probably more frequent, its underlying
disease process being different from that of primary
aneurysms. Because only few studies have followed
up patients conservatively for reasons not related to
the risk of rupture, we decided to use a rather high
rupture rate of 10% per year in the base-case analyses
(which is similar to the rupture rate of large primary
abdominal aneurysms),14 decreasing the rate to 1.5%
in the sensitivity analyses.
Another parameter lacking evidence-based infor-
mation was the sensitivity of ultrasound (duplex) and
CT scan to detect a false aneurysm. For primary
aneurysms, it is assumed to be close to 100%, although
the frequent occurrence of gas in the bowel is likely to
result in a lower detection rate. Because its sensitivity
to detect a false aneurysm is largely unknown, we
planned sensitivity analyses for values in the range of
90–99% for ultrasound and assumed a high sensitivity
of 98% for a CT scan.
The model includes direct medical costs of diag-
nostic procedures and surgery for the Dutch situation.
Real costs of diagnostic procedures were obtained
from a detailed analysis in our institution and charges
were used to value the various surgical procedures
(Table 2). Costs are given in Euros (1 Euro < 1 US
Dollar) and were adjusted to the 2001 price level.
Results
Corresponding to the underlying model assumptions,
the cumulative incidence of false aneurysms increased
over time, while the proportion of patients surviving
decreased rapidly to 24% at 20 years Among these
surviving patients, the rate of false aneurysm devel-
opment increased, particularly after 5 years, with a
cumulative incidence of up to 31% at 10 years. Of
patients surviving at least 20 years, as many as 50%
developed a false aneurysm (Fig. 1).
Aorto-bi-iliac prostheses
Our reference strategy without routine follow-up
yielded 7.5 life years at a cost of 1900 Euro. On
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average 12% of patients developed a false aneurysm
during life, which resulted in a life-threatening
rupture in 6% of patients (Table 3). As a result of
annual follow-up by ultrasonography, elective surgery
was performed in 22% of the patients (including
multiple surgery), and prevented a rupture in 4% of
the patients. This resulted in higher costs (3800 Euro
per patient), but not in a higher life expectancy or
QALYs (Table 3). Because the incidence of false
aneurysms is most notable 5–15 years after surgery,
we examined specifically whether starting follow-up
after 5, 10 or 15 years would increase QALYs. These
strategies resulted in a small but non-significant
improvement in cost-effectiveness. The results of the
sensitivity analyses are shown in Table 4. Whilst lower
rupture rates had no effect, an annual rate of rupture
higher than 10% is unlikely. Increasing the specificity
of ultrasound up to 99% did not improve the
performance of routine follow-up. When mortality of
elective surgery was assumed to be 2% or lower, a
slight improvement, 7.56 [CI 7.52–7.60] QALYs (vs.
7.50), was achieved. The assumption of a lower
relative mortality risk (of vascular patients vs. the
general population) of 1.9 instead of 3.1 did not result
in any improvement. The outcome was, however,
sensitive for the mean patient age. For patients aged 54
or younger, routine follow-up improved the outcome
as compared to no follow-up, resulting in a significant
gain of 0.11 QALYs (95% CI 0.07–0.15). A similar, but
not stronger effect, was obtained at age 52 or lower.
Therefore, we tested the same set of strategies
specifically at age 54 (Table 5). Starting follow-up 10
years after surgery and extending it to 30 years was the
most cost-efficient strategy (10.72 QALYs at a cost of
4600 Euro; cost-effectiveness ratio 21,250 Euro). Start-
Table 1. Estimates of the model parameters, obtained by literature review (weighted averages)
Parameter Estimate Value base case (range) References Patients
Age (standard dev) 63 (8) 63 (SD 8)
Proportion male 78% 78%
Annual incidence false aneurysm 1% 1% 1,4–6,17–20
Annual incidence occlusion 2.6% 2.6% 20–23 3208
Annual incidence graft infection 0.5% 0.5% 20,21,24–27 9264
Annual incidence rupture 1.5–10%* 10% (1.5–10%) 6,28,29 23
Relative mortality risk 3.1 3.1 (1.9–3.1) 30
Mortality elective surgery for abdominal false aneurysm 5.9% 5.9% (2.0–4.5%) 3,28,29,31–36 871
Mortality elective surgery for femoral false aneurysm 0.1% 0.1% Expert op. –
Mortality surgery for graft infection 19%† 19%† 26,27,37–45 565
Mortality surgery for occlusion 2% 2% Expert op. opinion –
Mortality surgery for ruptured femoral false aneurysm 0.1% 0.1% Expert op. –
Mortality surgery for ruptured abdominal false aneurysm 47% 47% 2,3,32,46–49 636
Immediate mortality abdominal rupture 59% 59% 47–49 189
Sensitivity duplex 95% 95% (90–99%) Expert op. –
Specificity duplex 95% 95% (90–99%) Expert op. –
Sensitivity CT scan 98% 98% Expert op. –
Specificity CT scan 99% 99% Expert op. –
Utility during surgery 0.05 0.05 Expert op. –
Utility after surgery 1 1 Expert op. –
*See comments in text.
† þ 35% per year in excess.
Table 2. Costs associated with diagnostic and surgical procedures
Procedure Costs (Euro)
Diagnostic procedure
Duplex scan e 63
CT-scan e 304
Surgery
Elective surgery for abdominal false aneurysm e 5,484
Elective surgery for femoral false aneurysm e 3,645
Surgery for ruptured abdominal false aneurysm e 12,555
Surgery for ruptured femoral false aneurysm e 3,645
Surgery for graft occlusion e 5,484
Surgery for graft infection e 12,555
Fig. 1. Cumulative incidence of false aneurysms (for all and
for surviving patients) and probability of death for patients
who underwent aorto-iliac prosthetic reconstruction.
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ing follow-up as early as 5 years after primary surgery
did not improve the outcome, but stopping after 15 or
20 years was slightly worse.
Aorto-distal tube and aorto-bifemoral prostheses
Although this type of prosthesis has one anastomosis
less at risk, the risk of life-threatening rupture is also
present for aorto-distal tube prostheses. Annual
follow-up resulted in the same QALYs as no follow-
up, although it reduced the number of ruptures to 3%.
Starting follow-up after an interval of 5 or 10 years
provided the same result, albeit at lower costs.
Restricting the analyses to patients below 55 years of
age did not improve the outcome for routine follow-
up.
Patients with aorto-bifemoral prostheses exhibited
a life expectancy of 7.62 years whether or not they
were followed up with regular ultrasound (Table 3).
This result was insensitive to variation in any of the
model parameters.
Discussion
The aim of follow-up of aorto-iliac prostheses is to
prevent life-threatening rupture of false aneurysms.
Previously, it has been demonstrated that long-term
survivors incur a substantial risk to develop a false
aneurysm after aorto-iliac prosthetic reconstructions.1
Therefore, we have been offering our patients with
regular ultrasound follow-up. In the present report,
we find that routine follow-up for patients, with aorto-
bifemoral or aorto-distal tube prostheses, is not cost-
effective. In contrast, annual duplex follow-up of
aorto-bi-iliac prostheses (preferably starting 10 years
after surgery) appeared to be beneficial and cost-
effective for patients with initial surgery at age 54 or
younger. A further improvement in life expectancy
was observed when perioperative mortality for elec-
tive surgery of an abdominal false aneurysm was 2%
or less. This figure is probably only realistic for
selected patients in a few excellent surgical centres,
unless endovascular treatment is used.15,16 If endo-
vascular treatment of false aneurysms is available,
follow-up could be extended to patients over a broader
age range. However, it is important to realize that this
small benefit can only be expected if the yearly rupture
rate of false aneurysms is 10% or higher (being the
rupture risk of large primary aneurysms). It is possible
that false aneurysms incur a much lower risk. In that
case, surveillance of aortobi-iliac prostheses would not
result in an improvement of life expectancy and
should be avoided at all ages.
As is illustrated in Fig. 1, the survival curve of
patients who underwent prosthetic aorto-iliac recon-
struction forms an inverse relationship with the
probability of developing a false aneurysm. This
explains why prevention of 3% of ruptures does not
necessarily result in an increase in life expectancy. The
high incidence of cardiovascular mortality in this
patient group outweighs the mortality risk due to
rupture of a false aneurysm.
Whereas a beneficial effect of follow-up was
observed for aorto-iliac prostheses under specific
favourable conditions, no benefit was observed for
aorto-distal tube prosthesis or femoro-distal pros-
theses whatever the circumstances. This might be
explained by the number of anastomoses at risk of life-
threatening rupture, i.e. three for aorto-biiliac, two for
aorto-distal, and only one anastomosis at risk for
aorto-bifemoral prostheses. A clinically-relevant false
Table 3. Main results of the base-case cost-effectiveness analyses for the three types of prostheses
Strategy Average per patient (1.96 £ standard error)
QALYs Costs £ e 1000 Tests Operations Ruptures
Aorto-bi-iliac prostheses
No follow-up 7.50 (0.04) 1.9 (0.05) – – 6%
Annual 7.49 (0.04) 3.8 (0.07) 8 22% 2%
Biennial 7.53 (0.04) 3.0 (0.06) 4 14% 3%
5–30 yrs annual 7.53 (0.04) 3.4 (0.07) 5 23% 2%
10–30 yrs annual 7.54 (0.04) 2.7 (0.06) 3 16% 3%
15–30 yrs annual 7.53 (0.04) 2.3 (0.06) 1 10% 4%
Aorto-distal tube prostheses
No follow-up 7.53 (0.04) 1.9 (0.05) – – 5%
Annual 7.53 (0.04) 3.7 (0.07) 8 20% 2%
10–30 yrs annual 7.53 (0.04) 2.7 3 15% 3%
Aorto-bi-femoral prostheses
No follow-up 7.62 (0.04) 1.9 (0.05) – – 2%
Annual 7.58 (0.05) 3.7 (0.07) 9 23% 1%
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femoral aneurysm will be discovered readily by the
patient. Clinical consultation will result in detection of
this false aneurysm, even in the absence of a formal
follow-up program.
Methodological limitations
A criticism that may be raised against our analyses is
the lack of reliable information regarding the rupture
risk of false aneurysms. Little is known about the
natural course of false aneurysms. Primary (true)
abdominal aortic aneurysms incur a risk of rupture
that is related to their diameter.10,11 Moreover, the risk
of fatal rupture for patients with abdominal aortic
aneurysms smaller than 5.5 cm does not outweigh the
mortality risk of elective surgery and is estimated
between 0.6% and 2% per year.12,13 For an aneurysm
larger than 5.5 cm, the risk of rupture is estimated at
10% per year.14 Whether such a relationship between
diameter and rupture risk also exists for false
aneurysms is questionable, and not supported by the
literature. We therefore used a simplified model of the
natural course of false aneurysms, assuming that such
a relationship does not exist. The overall rate of
rupture was estimated from the literature at 1.5% per
year. However, because this may underestimate the
true rate of rupture for reasons discussed previously,
we used a rather high rate of rupture, similar to that of
large primary abdominal aneurysms (10% per year) in
our analyses.
For the data on the incidence and natural course of
false aneurysms, we included both patients whose
reconstruction was undertaken because of aorto-iliac
occlusive disease and patients who were operated for
a primary abdominal aneurysm. We realize that there
may be differences in vascular characteristics, and in
the incidence of false aneurysms between these two
groups. However, because no objective information
exists on these possible differences, we decided to
combine the two groups.
Another parameter lacking precise information is
the accuracy of ultrasound and CT scanning for
detecting an abdominal or femoral false aneurysm.
As described in the Methods, we used a broad range
for the sensitivity (95–99%) and assumed a high
specificity (95% for ultrasound; 99% for CT scanning).
However, the results were not sensitive to this
parameter.
The fact that we used a model to combine empirical
data may be another criticism of our study. However,
we believe our approach is the only feasible way to
combine such diverse data, and thereby analyze the
potential benefit of various follow-up strategies afterTa
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aorto-iliac reconstruction. Moreover, if the most
promising strategy (i.e. annual follow-up starting 10
years after surgery) were to be tested in a randomised
trial, a large number of patients would need to be
followed up for at least 20 years. Such a trial would be
a costly and long-lasting exercise of which the result
may be out of date at the moment of its disclosure and
is, in our view, not a realistic alternative to our
approach.
Conclusions
Annual follow-up after aortic surgery is indicated for
patients with aorto-bi-iliac prostheses only, and should
be restricted to patients aged 54 or younger and not
start before 10 years after surgery (Fig. 2). The same
strategy can only be considered for older patients if
perioperative mortality is below 2%. Since patients
with aorto-distal tube and aorto-bi-femoral prostheses
do not gain anything by follow-up, this practice
should be discouraged in these patient groups.
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Appendix
Appendix A
The risk of a false aneurysm originating per cycle of 3
months (0.25 year) is represented by the formula
R ¼ 12 Expð2ðI  ðð1 þ FÞTÞÞ  0:25Þ
in which
Table 5. Main results of cost-effectiveness analyses for aorto-biiliac prosthetic reconstruction at age 54
Strategy Average per patient (1.96* standard error)
QALYs Costs* e 1000 CE ratio* Ruptures Tests Operations
Yearly routine testing
No follow-up 10.64 (0.04) 2.9 (0.05) – 11% – –
Annual 1–30 years 10.71 (0.04) 6.3 (0.09) e 48.000 3% 13 48%
Annual 1–15 years 10.65 (0.04) 5.4 (0.06) – 6% 11 29%
Annual 5–20 years 10.65 (0.04) 5.2 (0.06) – 5% 8 35%
Annual 5–15 years 10.69 (0.04) 4.7 (0.06) – 6% 7 24%
Annual 10–15 years 10.68 (0.04) 3.8 (0.05) – 7% 3 14%
Annual 10–20 years 10.68 (0.04) 4.2 (0.06) – 6% 5 24%
Annual 10–30 years 10.72 (0.04) 4.6 (0.06) e 21.250 4% 6 33%
Once after 10 years 10.65 (0.04) 3.2 (0.05) – 10% 1 4%
Every 5 years 10.64 (0.04) 3.5 (0.05) – 8% 2 11%
*Compared with no follow-up.
Fig. 2. Recommended strategy for follow-up after aorto-iliac prosthetic reconstruction.
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R ¼ false aneurysm risk for a specific cycle
I ¼ initial incidence rate;
F ¼ fractional rate increase per year;
T ¼ time in years since initial surgery;
and 0.25 is the duration (in years) of 1 cycle.
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